LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay— 510(k) DEN170010

Unknown

Lin-Zhi International, Inc.

FDA 510(k) clearance DEN170010 for LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay, Unknown on 2018-04-20. Applicant: Lin-Zhi International, Inc..

Clearance details

Applicant: Lin-Zhi International, Inc.
Product code: Code QBK
Advisory panel: Clinical Toxicology
Date received: 2017-02-21
Decision date: 2018-04-20
Decision: Unknown
Clearance type: Direct
Location: Santa Clara, CA, US

View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.